Newsroom

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On August 15, 2025, Scorpion Capital published a report that described Soleno’s only product, V...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Car-Mart, Inc. (“Car-Mart” or the “Company”) (NASDAQ:CRMT) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On July 15, 2025, Car-Mart disclosed it would delay filing its annual report because “management identified the need t...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) investors of the January 5, 2026 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Inspire securities between August 6, 2024 through August 4, 2025 (“the Class Period”). Follow the link below for more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Is The Lawsuit About? The lawsuit allege...

SAN DIEGO--(BUSINESS WIRE)--Altium today announced the appointment of Don Cantow as General Manager of Altium, effective January 1, 2026....

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Trex Company, Inc. (“Trex” or the “Company”) (NYSE:TREX) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On August 2025, Trex assured investors that “our revised inventory strategy reduces the volatility typically asso...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ON24, Inc. (NYSE: ONTF) to Cvent. Under the terms of the proposed transaction, shareholders of ON24 will receive $8.10 in cash for each share of ON24 that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration underv...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of FONAR Corporation (NasdaqCM: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company. Under the terms of the proposed transaction, shareholders of FONAR will receive $19.00 per share of the Company's common stock, $19.00 per share of the Co...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Flushing Financial Corp. (NasdaqGS: FFIC) to OceanFirst Financial Corp. (NasdaqGS: OCFC). Under the terms of the proposed transaction, shareholders of Flushing Financial will receive 0.85 of a share of OceanFirst common stock for each share of Flushing Financial that they own. KSF is seeking to dete...

アラブ首長国連邦ドバイ--(BUSINESS WIRE)--（ビジネスワイヤ） -- メドケア・ウィメンズ・アンド・チルドレン病院は、トルコ出身の3歳の患者であるフルス君に対し、脊髄性筋萎縮症（SMA）に対する画期的な髄腔内遺伝子治療に成功しました。この画期的な出来事により、メドケアは、年齢と体重の制限を克服し、高齢の外国人患者にもこの革新的治療を提供できる世界初の民間医療機関の1つとなりました。 SMAは、運動と呼吸を担う筋肉が徐々に衰弱していく神経筋に関連する希少疾患です。新たに承認されたこの単回治療は、機能的なSMN1遺伝子を投与することで、根本的な遺伝的原因に対処します。 以前は集中的な理学療法と水治療法に頼っていたフルス君にとって、メドケアによる治療は、生涯にわたる注射に代わる有望な選択肢となりました。父親のムスタファさんは、長年のリハビリにもかかわらず、この治療法によって息子の自立と生活の質の向上への希望を持てるようになったと語りました。 メドケア病院・医療センターのグループCEOであるシャニラ・ライジュは、「これは、この地域におけるSMA治療における決定的瞬間です。これ...

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS), a global intelligent beauty and wellness leader, today released its 2024 Social Impact and Sustainability Report. The report outlines progress on the company’s environmental and social priorities, including its sustainability commitments and global giving efforts. “Nu Skin has always been guided by a powerful purpose – to empower people to look, feel and live better,” said Ryan Napierski, Nu Skin president and CEO. “That missi...